Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06054412 · ClinicalTrials.gov registry record · NA

An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers

A NA study of Post Traumatic Stress Disorder and Well-Being, Psychological, sponsored by Wayne State University.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06054412: Active NA study of Post Traumatic Stress Disorder and Well-Being, Psychological, sponsored by Wayne State University.

NCT06054412 is a NA study of Post Traumatic Stress Disorder and Well-Being, Psychological that is active but no longer recruiting, run by Wayne State University. The registered enrollment target is 20 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06054412, a NA study of Post Traumatic Stress Disorder and Well-Being, Psychological, is active but no longer recruiting, sponsored by Wayne State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The proposed study will collect novel data evaluating the feasibility of the NFB training program delivered in an outpatient mental health setting and its influence on mothers' overall sense of well-being, and further investigate whether enhanced well-being is associated with positive changes in emotion regulation capacities, trauma-related mental health symptoms, parenting behaviors and attitudes, and infant behavioral outcomes (i.e., crying, fussing) among postpartum mothers with a history of childhood trauma and clinically concerning trauma-related mental health symptoms.

Primary Outcome

To measure maternal well-being. Minimum score = 9 Maximum score = 45 Higher scores mean a better outcome.

Interventions

  • DEVICE Neuroptimal (Zengar, Inc.) Neurofeedback

Study Locations (1)

Michigan

  • Wayne State University - Detroit

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-03-03
Est. Completion 2025-12-01
Phase NA
Wayne State University

163 total trials

What the registry record for NCT06054412 still lists

NCT06054412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (97% lower).

The record links to 8 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Neuroptimal (Zengar, Inc.) Neurofeedback is the first listed.

NCT06054412 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06054412 about?

NCT06054412 is a clinical study titled "An Adjunctive Neurofeedback Training Program to Enhance Wellness Among Trauma-Exposed Postpartum Mothers". The proposed study will collect novel data evaluating the feasibility of the NFB training program delivered in an outpatient mental health setting and its influence on mothers' overall sense of well-being, and further investigate whether enhanced well-being is associated with positive changes in emo...

What is the current status of trial NCT06054412?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-03-03. Estimated completion is 2025-12-01.

What conditions does trial NCT06054412 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Well-Being, Psychological, Maternal Behavior, Emotional Regulation, Maternal Care Patterns.

What interventions are being tested in trial NCT06054412?

The interventions under investigation include: Neuroptimal (Zengar, Inc.) Neurofeedback (DEVICE).

Who is sponsoring clinical trial NCT06054412?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06054412 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06054412's enrollment target sits among peer trials

20 231st of 262 higher than 22 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06054412, the US trial registry maintained by the National Library of Medicine. NCT06054412 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.